<DOC>
	<DOCNO>NCT02504931</DOCNO>
	<brief_summary>The investigator propose conduct clinical trial evaluate sertraline treatment efficacy large sample military veteran dual diagnosis PTSD Alcohol Use Disorder receive Cognitive Behavioral Therapy part VA-system 's new dual diagnosis program . The study design efficacy trial sertraline use adjunct Cognitive Behavioral Therapy ( CBT ) treatment PTSD/Alcohol dual diagnosis . There two outcome interest , namely PTSD symptom improvement also decrease alcohol consumption . The investigator interest know whether sertraline superior placebo improve symptom either one two disorder . Even though sertraline treatment choice PTSD , investigator expect comorbid condition alcohol dependence complicate treatment PTSD cluster subgroup show differential treatment response sertraline . The primary objective present study identify subgroup alcohol dependent person PTSD either benefit benefit treatment SSRI 's . The propose study enroll veteran PTSD dually-diagnosed alcohol dependence 12-week treatment provide sertraline vs. placebo medication adjunct manualized CBT specifically test hypothesis subtypes alcohol dependence use predict patient respond well subgroup responds poorly SSRI treatment .</brief_summary>
	<brief_title>Serotonin Selective Reuptake Inhibitor Treatment Dual Diagnosis Post-traumatic Stress Disorder Alcohol Problems</brief_title>
	<detailed_description>Experimental Design . The study design parallel group , double-blind , placebo-controlled , stratified , randomized medication treatment trial male female veteran experience `` in-theater '' trauma PTSD Alcohol Use dual diagnosis . All subject receive 12 week manualized cognitive &amp; behavioral therapy standard care . Additionally , subject randomize 1:1 receive double-blind treatment Sertraline v . Placebo adjunctive treatment . The manualized therapy provide standard cognitive-behavioral therapy ( CBT ) address alcohol use prolonged exposure ( PE ) behavioral therapy target PTSD . Sertraline common treatment PTSD psychiatric disturbance hypothesize differential efficacy different subtypes alcohol drinking patient . A stratified randomization scheme balance placebo sertraline assignment two group , post-hoc clustering approach use determine subgroup dual diagnosis patient may benefit sertraline vs. placebo treatment . Veterans PTSD regularly drink 5 standard drink alcohol day ( note one 12oz beer = one standard drink ) may eligible study meet criterion .</detailed_description>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>2165 year old Veterans PTSD regularly drink 5 standard drink alcohol day experience trauma deployment regularly drink 5 standard drink alcohol interested come per week 12 week dual diagnosis individual therapy willing participate placebocontrolled trial could include receipt sertraline ( Zoloft ) . PTSD Symptoms adequately control medication regimen ; require inpatient alcohol detoxification ; currently receive naltrexone , disulfiram , acamprosate , ondansetron treatment alcohol dependence ; currently unstable medical illness ; bipolar psychotic disorder ; currently take unwilling discontinue take SSRI , SNRI , MAO inhibitor , tricyclic antidepressant , anticonvulsant .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>PTSD</keyword>
	<keyword>Alcohol</keyword>
	<keyword>Dual Diagnosis</keyword>
	<keyword>Sertraline</keyword>
	<keyword>SSRI</keyword>
</DOC>